Second Sight Reports Second Quarter 2016 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three- and six-month periods ended June 30, 2016. Recent Company Highlights: Completed oversubscribed Rights Offering, giving the Company access to an additional $19.5 million to fund ongoing trials and research; Gener
